MedPath

NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES

๐Ÿ‡บ๐Ÿ‡ธUnited States
Ownership
-
Employees
-
Market Cap
-
Website

Lamivudine and Adefovir to Treat Chronic Hepatitis B Infection in People With and Without HIV Infection

Phase 3
Completed
Conditions
HIV Infections
Chronic Hepatitis B
First Posted Date
2001-08-27
Last Posted Date
2008-03-04
Lead Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Target Recruit Count
100
Registration Number
NCT00023153
Locations
๐Ÿ‡บ๐Ÿ‡ธ

National Institute of Allergy and Infectious Diseases (NIAID), Bethesda, Maryland, United States

A Randomized, Double-Blinded, Placebo-Controlled, Phase II Inhaled Interferon Gamma-1b and Antimycobacterials to Treat Pulmonary Mycobacterium Avium Complex Infections

Phase 2
Completed
Conditions
Mycobacterium Avium-Intracellulare Infection
First Posted Date
2001-07-25
Last Posted Date
2008-03-04
Lead Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Target Recruit Count
20
Registration Number
NCT00021567
Locations
๐Ÿ‡บ๐Ÿ‡ธ

National Institute of Allergy and Infectious Diseases (NIAID), Bethesda, Maryland, United States

Study of Mycobacterial Infections

Recruiting
Conditions
Mycobacterium Infections
Interventions
First Posted Date
2001-06-29
Last Posted Date
2024-12-27
Lead Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Target Recruit Count
1000
Registration Number
NCT00018044
Locations
๐Ÿ‡บ๐Ÿ‡ธ

National Institutes of Health Clinical Center, Bethesda, Maryland, United States

Peginterferon Alpha-2b And Ribavirin to Treat Hepatitis C in HIV-Infected Patients

Phase 2
Completed
Conditions
Hepatitis C
HIV Infections
Interventions
First Posted Date
2001-06-28
Last Posted Date
2014-10-01
Lead Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Target Recruit Count
36
Registration Number
NCT00018031
Locations
๐Ÿ‡บ๐Ÿ‡ธ

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States

Emergency Use of Voriconazole in Patients With Life-Threatening Invasive Fungal Infections

Phase 3
Completed
Conditions
Mycoses
First Posted Date
2001-04-30
Last Posted Date
2008-03-04
Lead Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Target Recruit Count
40
Registration Number
NCT00015665
Locations
๐Ÿ‡บ๐Ÿ‡ธ

National Institute of Allergy and Infectious Diseases (NIAID), Bethesda, Maryland, United States

Immune System and Gut Abnormalities in Patients With Common Variable Immunodeficiency With and Without Gastrointestinal Symptoms

Completed
Conditions
Common Variable Immunodeficiency
First Posted Date
2001-04-19
Last Posted Date
2019-03-29
Lead Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Target Recruit Count
30
Registration Number
NCT00015431
Locations
๐Ÿ‡บ๐Ÿ‡ธ

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States

HIV Maintenance Therapy With T-20 During HAART Interruption

Phase 2
Completed
Conditions
HIV Infection
First Posted Date
2001-04-02
Last Posted Date
2008-03-04
Lead Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Target Recruit Count
10
Registration Number
NCT00013884
Locations
๐Ÿ‡บ๐Ÿ‡ธ

National Institute of Allergy and Infectious Diseases (NIAID), Bethesda, Maryland, United States

Pyrimethamine and Sulfadoxine for Treatment of Autoimmune Lymphoproliferative Syndrome

Phase 1
Completed
Conditions
Autoimmune Disease
Lymphoproliferative Disorder
First Posted Date
2001-03-29
Last Posted Date
2008-03-04
Lead Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Target Recruit Count
8
Registration Number
NCT00013689
Locations
๐Ÿ‡บ๐Ÿ‡ธ

National Institute of Allergy and Infectious Diseases (NIAID), Bethesda, Maryland, United States

Adefovir Dipivoxil to Treat Hepatitis B in HIV-Infected Patients

Phase 2
Completed
Conditions
Hepatitis B
HIV Infection
First Posted Date
2001-03-29
Last Posted Date
2008-03-04
Lead Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Target Recruit Count
30
Registration Number
NCT00013702
Locations
๐Ÿ‡บ๐Ÿ‡ธ

National Institute of Allergy and Infectious Diseases (NIAID), Bethesda, Maryland, United States

HIV-1 Vaccine Test in Uninfected Adult Volunteers

Phase 1
Completed
Conditions
Healthy
HIV Seronegativity
First Posted Date
2001-02-05
Last Posted Date
2008-03-04
Lead Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Target Recruit Count
21
Registration Number
NCT00009685
Locations
๐Ÿ‡บ๐Ÿ‡ธ

National Institute of Allergy and Infectious Diseases (NIAID), Bethesda, Maryland, United States

ยฉ Copyright 2025. All Rights Reserved by MedPath